Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Sector Advances in Pancreatic Cancer Research

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 22.47 (+1.44%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
NVS : 95.92 (-1.39%)
IBRX : 5.23 (+1.95%)
ACRS : 1.1500 (-1.71%)
NUVB : 2.26 (-0.88%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 2.45 (-8.24%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
NVS : 95.92 (-1.39%)
IBRX : 5.23 (+1.95%)
ACRS : 1.1500 (-1.71%)
NUVB : 2.26 (-0.88%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth

EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
BLRX : 1.1499 (-0.01%)
IMRX : 2.5600 (+34.03%)
CADL : 1.4000 (-6.67%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - March 6, 2024) - Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on developments...

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END

OCEA : 4.05 (-1.70%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
LVTX : 2.94 (-0.34%)
MRK : 121.44 (-0.07%)
ABBV : 178.49 (+0.34%)
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
LVTX : 2.94 (-0.34%)
MRK : 121.44 (-0.07%)
ABBV : 178.49 (+0.34%)
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

 US$5M grant supports study of pelareorep in combination with modified FOLFIRINOX +/- atezolizumab   Testing with the most common therapies could facilitate broad use of pelareorep in pancreatic cancer...

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced it has submitted...

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced that it will host...

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced that Chief...

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)

Barchart Exclusives

3 AI Chip Stocks That Look More Overvalued Than Nvidia Right Now
The breakout rally in AI stocks, with Nvidia leading the charge, has raised concerns about a potential bubble. However, with NVDA now down about 10% from its recent highs, here are three AI chip stocks that look even more expensive than the industry leader. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar